转移生长因子β受体2抗体(TGF beta Receptor II) 价格￥980 起批量≥1支 最小起订1支 供货总量50支 发货地址浙江省温州市 建议售价￥980/支 更新日期2025年01月21日 产品规格50ul 即时洽谈立即询价查看联系方式 收藏产品发送留言 VIP3年 温州科淼生物科技有限公司 ...
TGF-beta receptor 2 downregulation in tumour-asso- ciated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study. BMC Cancer. 2007;7:156....
关键字:Recombinant Human TGFBR2/TGF-beta receptor type-2;细胞生物学 公司简介 北京索莱宝科技有限公司是一家集研发、生产、销售、服务于一体的高科技生物企业。技术推广;技术转让;技术咨询;技术服务;生物试剂技术开发;销售生物试剂盒、实验室专用化学试剂、实验室专用设备、办公用品、化工产品(不含危险化学品)、计...
上海玉博生物科技有限公司 主要致力于“TGF-beta Receptor II (K105) Antibody CST 3713S”的生产销售。多年的“TGF-beta Receptor II (K105) Antibody CST 3713S”生产与销售的经验,与各行业新老用户建立了稳定的合作关系,我公司经营的产品名称深受广大用户信赖。欢迎来
TGF-B (Transforming growth factor-beta superfamily members are critical regulators of cell proliferation,differentiation,morphogenesis,and pathogenesis. TGF-beta receptor is a serine/threonine kinase receptor complex that consists of two distinct tra
Only few tumours showed expression of TGF-β receptors (27% or 84 of 309 for type1; 5% or 14 of 295 for type 2). The rate of receptor expression was not linked to histological grade, regional or distant metastasis or survival. In the majority of tumours (nuclear or cytoplasmatic) expre...
TGF beta 2重组蛋白;高活性/TGF beta 2 protein价格:￥710/支产品详情:中文名称:(TGFβR2)重组蛋白 英文名称:Recombinant Transforming Growth Factor Beta Receptor II (TGFbR2) 英文简... 纯度:95% 包装规格:10ug/50ug/100ug/1mg 用途:仅供科研使用 ...
英文名称: TGFR-2; TGF-beta type II receptor; TGF-beta receptor type 2; TbetaR-II 总访问: 19 国产/进口: 进口 半年访问: 2 产地/品牌: MedChemExpress(MCE) 产品类别: 生化试剂 规格: 2μg; 10 μg; 50 μg; 100 μg; 500 μg 最后更新: 2024-11-4 货号: HY-P77229 CAS 号: ...
Transforming Growth Factor 1 Receptor II Is Downregulated by E1A in Adenovirus-Infected Cells The levels of TGF-β1 receptor II (TβRII) in adenovirus-infected cells were decreased, and this decrease was mapped, by using virus mutants, to the... V.,L.,Tarakanova,... - 《Journal of Viro...
Fusion proteins comprising the TGF-beta Type II receptor linked to a portion of an immunoglobulin constant chain are described. Also described are methods of using the fusion proteins of the invention to treat a variety of fibroproliferative disorders. Inventors...